| | AstraZeneca commences review of strategic options for Astra Tech | | | AstraZeneca today announced that it has formally commenced a review of its strategic options for Astra Tech. Astra Tech develops, manufactures and markets dental implants and healthcare (urological and surgical) products. AstraZeneca continues to evaluate all alternatives for value maximisation from this business and any final decision will only be made when the results of the review have concluded. During the period of this review, AstraZeneca remains committed to supporting Astra Tech's business, customers and stakeholders. | |  View full press release | | | This email has been sent via AstraZeneca's email alert service. Update your email preferences, unsubscribe from this service or contact us. | | | |
No comments:
Post a Comment